BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28616934)

  • 1. Temporal Trends in the Prevalence and Incidence of Diagnosed ADHD in Children and Young Adults between 1999 and 2012 in Canada: A Data Linkage Study.
    Vasiliadis HM; Diallo FB; Rochette L; Smith M; Langille D; Lin E; Kisely S; Fombonne E; Thompson AH; Renaud J; Lesage A
    Can J Psychiatry; 2017 Dec; 62(12):818-826. PubMed ID: 28616934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimating the Prevalence and Incidence Rate of Autism Spectrum Disorder (ASD): Interprovincial Comparisons].
    Diallo FB; Pelletier É; Vasiliadis HM; Rochette L; Lin E; Smith M; Langille D; Thompspon A; Noiseux M; Vanasse A; St-Laurent D; Kisely S; Fombonne É; Lesage A
    Sante Ment Que; 2018; 43(2):65-81. PubMed ID: 32338686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of administrative data for the surveillance of mental disorders in 5 provinces.
    Kisely S; Lin E; Lesage A; Gilbert C; Smith M; Campbell LA; Vasiliadis HM
    Can J Psychiatry; 2009 Aug; 54(8):571-5. PubMed ID: 19726010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
    Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
    Brault MC; Lacourse É
    Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends and geographical variability of the prevalence and incidence of attention deficit/hyperactivity disorder diagnoses among children in Catalonia, Spain.
    Pérez-Crespo L; Canals-Sans J; Suades-González E; Guxens M
    Sci Rep; 2020 Apr; 10(1):6397. PubMed ID: 32286454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Has the prevalence of parent-reported diagnosis of attention deficit hyperactivity disorder (ADHD) in Germany increased between 2003-2006 and 2009-2012? Results of the KiGGS-study: first follow-up (KiGGS Wave 1)].
    Schlack R; Mauz E; Hebebrand J; Hölling H;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jul; 57(7):820-9. PubMed ID: 24950831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates.
    Brownell MD; Yogendran MS
    Can J Psychiatry; 2001 Apr; 46(3):264-72. PubMed ID: 11320681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Benchimol EI; Bernstein CN; Bitton A; Carroll MW; Singh H; Otley AR; Vutcovici M; El-Matary W; Nguyen GC; Griffiths AM; Mack DR; Jacobson K; Mojaverian N; Tanyingoh D; Cui Y; Nugent ZJ; Coulombe J; Targownik LE; Jones JL; Leddin D; Murthy SK; Kaplan GG
    Am J Gastroenterol; 2017 Jul; 112(7):1120-1134. PubMed ID: 28417994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in incidence rates of diagnosed attention-deficit/hyperactivity disorder (ADHD) over 12 years in Taiwan: A nationwide population-based study.
    Huang CL; Wang JJ; Ho CH
    Psychiatry Res; 2020 Feb; 284():112792. PubMed ID: 31981938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective.
    Štuhec M; Švab V; Locatelli I
    Croat Med J; 2015 Apr; 56(2):159-65. PubMed ID: 25891876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender ratios of administrative prevalence and incidence of attention-deficit/hyperactivity disorder (ADHD) across the lifespan: A nationwide population-based study in Taiwan.
    Huang CL; Weng SF; Ho CH
    Psychiatry Res; 2016 Oct; 244():382-7. PubMed ID: 27525828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision.
    Schlander M; Schwarz O; Trott GE; Viapiano M; Bonauer N
    Eur Child Adolesc Psychiatry; 2007 Oct; 16(7):430-8. PubMed ID: 17468967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of administrative data for the surveillance of mood and anxiety disorders.
    Kisely S; Lin E; Gilbert C; Smith M; Campbell LA; Vasiliadis HM
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1118-25. PubMed ID: 20001410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends in incidence rates of diagnosed attention-deficit/hyperactivity disorder across 16 years in a nationwide Danish registry study.
    Mohr Jensen C; Steinhausen HC
    J Clin Psychiatry; 2015 Mar; 76(3):e334-41. PubMed ID: 25830455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios.
    Huỳnh C; Kisely S; Rochette L; Pelletier É; Morrison KB; Li S; Hopkin G; Smith M; Burchill C; Lin E; Asbridge M; Jutras-Aswad D; Lesage A
    Can J Psychiatry; 2022 Feb; 67(2):117-129. PubMed ID: 34569874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and regional variations in the administrative prevalence of attention-deficit/hyperactivity disorder among children and adolescents in Germany.
    Akmatov MK; Steffen A; Holstiege J; Hering R; Schulz M; Bätzing J
    Sci Rep; 2018 Nov; 8(1):17029. PubMed ID: 30451896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime Prevalence of Attention-Deficit Hyperactivity Disorder in Young Adults: Examining Variations in the Socioeconomic Gradient.
    Yallop L; Brownell M; Chateau D; Walker J; Warren M; Bailis D; Lebow M
    Can J Psychiatry; 2015 Oct; 60(10):432-40. PubMed ID: 26720190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.